Anda Pharmaceuticals Inc
Dr. Herrera joined the Scientific Advisory Board of PharmaEngine in November 2008. He created the Foundation of Alain Oncology Consulting in November 2008 after heading for ten years the oncology business at Sanofi-Aventis where he was successively Vice President responsible for Global Oncology Business Strategy and Development (2007-2008) and Head of Global Oncology Franchise (1998-2007) and contributed to the worldwide registration of two products: oxaliplatin (ELOXATINâ) and rasburicase (FASTURTECâ/ELITEKâ) as well as the gastric and head & neck indications for docetaxel (TAXOTEREâ). He received his M.D. from Pitié-Salpétrière Hospital, Faculty of Medicine, Paris, France.